Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook to 2024 -

Report Highlights

  • Nanoparticle Drug Market: US$ 200 Billion Opportunity By 2024
  • Global Pipeline For Nanoparticle Drug: 231 Drugs
  • Drugs In & Above Phase II Trials: 33 Drugs
  • Marketed Nanoparticle Drugs: 13 Drugs
  • Dosage, Price & Patent Analysis Of Key Drugs
  • Upcoming Nanoparticle Drug Delivery Techniques
  • Global Nanoparticle Drug Clinical Pipeline by Company, Indication & Phase

This research report on global nanoparticle drug delivery market provides an in-depth analysis of the market with special emphasis on the global market size, current market trends, dynamics and other factors that might have an impact on the market. Comparative price, dosage and therapy cost analysis of original drugs with nanoparticle formulations analyses the promising potential of Nanoparticle drug delivery, ultimately proving its superiority.

The research estimates the global nanoparticle drug market to reach over US$ 200 Billion by 2024 at a CAGR of 10%. Growth promoting factors like increase in global prevalence of various clinical indications like cancer, diabetes and rheumatoid arthritis are bound to fuel the market growth with oncology being the dominant segment. The increasing demand for effective treatment methods to provide for the rising pool of patients are expected to help the segment retain dominance over the report's forecast period as well.

Advancement in nanotechnology has resulted in the entry of many types of nanoparticles in the market. Nanocrystal and liposomes are currently the most popular nanoparticles in use, followed by micelles and dendrimers. Nanocrystal, liposomal and micelle formulations of therapeutics are being developed and marketed which is bound to increase the market size in the future.

Key Topics Covered

1. Nanoparticles - Revolutionizing Drug Delivery Method

2. Need for Nanoparticle Drug Delivery

3. Superiority of Nanoparticle Based Drug Delivery over Traditional Drug Delivery

4. Importance of Nanoparticle Drug Delivery in Cancer Therapy

5. Existing Techniques For Nanoparticle Drug Delivery

6. Upcoming Nanoparticle Drug Delivery Techniques

7. Global Nanoparticle Drug Market Overview

8. Price & Dosage Analysis of Commercially Available Nanoparticle Therapeutics

9. Nanoparticle Drug Delivery - Market Trend & Patent Distribution Analysis

10. Driving Factors of Nanoparticle Drug Delivery Market

11. Challenging Aspects of Nanoparticle Drug Delivery Segment

12. Future Forecast & Market Analysis of Global Nanoparticle Drug Delivery Market

13. Global Nanoparticle Drug Clinical Pipeline by Company, Indication & Phase

14. Marketed Nanoparticle Drug Clinical Insight by Company & Indication

15. Competitive Landscape

  • Abraxis BioScience
  • Access Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Amgen
  • Arrowhead Research
  • BIND Therapeutics
  • Cadila Healthcare
  • Celegen Corporation
  • Celsion Corporation
  • Genzyme Corporation
  • Merck
  • NanoCarrier
  • Nippon Kayaku
  • Nanobiotix
  • Novavax
  • Pfizer
  • Roche
  • Samyang
  • Sanofi
  • Takeda Pharmaceutical

For more information about this report visit

Back to news